CR6395A - Quimioterapia de combinacion - Google Patents
Quimioterapia de combinacionInfo
- Publication number
- CR6395A CR6395A CR6395A CR6395A CR6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A
- Authority
- CR
- Costa Rica
- Prior art keywords
- combination chemotherapy
- combination
- fenil
- paclitaxel
- compound
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
INHIBIDORES MITOTICO TALES COMO EL PACLITAXEL TIENEN ACTIVIDAD ANTITUMORAL MEJORADA UANDO SE USAN EN COMBINACION CON UN INHIBIDOR DE MEK SELECTIVO ESPECIALMENTE UN COMPUESTO FENIL AMINA DE LA FORMULA (I) Y (II).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11329198P | 1998-12-22 | 1998-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR6395A true CR6395A (es) | 2004-03-09 |
Family
ID=27733552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR6395A CR6395A (es) | 1998-12-22 | 2001-06-19 | Quimioterapia de combinacion |
Country Status (2)
Country | Link |
---|---|
CR (1) | CR6395A (es) |
ZA (1) | ZA200104277B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5651125B2 (ja) | 2008-12-10 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Mek阻害剤に対する耐性を付与するmek突然変異 |
RU2571930C2 (ru) | 2010-02-25 | 2015-12-27 | Дана-Фарбер Кэнсер Инститьют, Инк. | Мутации braf, обеспечивающие резистентность к ингибиторам braf |
WO2013169858A1 (en) | 2012-05-08 | 2013-11-14 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
-
2001
- 2001-05-24 ZA ZA200104277A patent/ZA200104277B/en unknown
- 2001-06-19 CR CR6395A patent/CR6395A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200104277B (en) | 2002-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2001002175A0 (en) | Combination chemotherapy. | |
RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
ATE516041T1 (de) | Synergistische zusammensetzungen mit fk-228 | |
MXPA06000247A (es) | Tetrahidro-1h-pirazolo[3,4-c]piridinas sustituidas composiciones que las contienen y su utilizacion. | |
HK1057553A1 (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents forthe inhibition of the cell proliferation. | |
MX2008016370A (es) | Buque de perforacion de actividad triple. | |
ID29076A (id) | Kombinasi senyawa aktif fungisida | |
HRP20080499T3 (en) | Tetrahydropyridothiophenes | |
BR9906070A (pt) | Benzamidas substituìdas | |
WO2004009616A3 (en) | Ghrelin analogs | |
JO2212B1 (en) | 4-PDE inhibitors for ethan substituted with three Ariel groups | |
GT199900173A (es) | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida. | |
DK1023268T3 (da) | Isoquinoliner som urokinaseinhibitorer. | |
DE60321594D1 (de) | Synergistische zusammensetzungen | |
AR048826A1 (es) | Composiciones antitranspirantes | |
DE50310323D1 (de) | Wässrige polyurethanzubereitungen | |
CR6395A (es) | Quimioterapia de combinacion | |
ITMI20031714A1 (it) | Formazioni ad azione antitumorale. | |
NO20052680D0 (no) | Forbedringsmiddel inneholdende brennstoff. | |
EP0995757A3 (en) | Bivalent inhibitors of the proteasome | |
AR026901A1 (es) | Peptidos con n-alquilacion que tienen actividad antiangiogenica | |
MXPA04003851A (es) | Antipruriticos. | |
MX9304152A (es) | Inhibidores de enzimas. | |
DE60011300D1 (de) | Inhibitoren der tryptase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |